|
Medical software provider Medipattern has signed a 38-site agreement with Doshi Diagnostic Imaging Services of New York and Florida to install its B-CAD-For-Life package, its breast care program.
Dilon Diagnostics, a molecular imaging systems manufacturer, has gained ISO 13485 certification for its Dilon 6800 Gamma Camera.
A new technique called personalized analysis of rearranged ends provides an accurate and specific way to monitor tumors by identifying personalized biomarkers from tumor DNA, according to a study published in the Feb. 24 issue of Science Translational Medicine.
Mammographic density measures that predict breast cancer are associated with at least two common genetic breast cancer susceptibility variants, according to a study published online in the February edition of the journal Cancer Research.
The addition of MRI scans to conventional triple assessment techniques for diagnosis of breast cancer has no effect on the reoperation rate, based on the COMICE trial published in the Feb. 13 issue of the Lancet.
Monday, February 08 2010
The chairman and CEO of SenoRx, Lloyd H. Malchow, is taking an indefinite medical leave of absence due to illness and John T. Buhler, president and chief operating officer of SenoRx, will serve as acting CEO.
Because mutations within the BRCA1 and BRCA2 genes are currently the strongest known predictors of ovarian cancer risk, at-risk family members should be offered genetic testing for the prevention of this deadly disease, wrote Cassandra Gulden and Olufunmilayo Olopade, both of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center, in an opinion piece in the February issue of the American Journal of Roentgenology
The radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and the reduction could be greater in women with larger and denser breasts, according to an American College of Radiology Imaging Network (ACRIN) trial in the February issue of the American Journal of Roentgenology.
Algeta, a cancer therapeutics company, and the Institute for Energy Technology (IFE), based in Oslo, are collaborating to manufacture and supply Alpharadin for future commercial use and in clinical trials.
Research published in this month’s issue of Cancer suggests that early FDG-PET imaging during preoperative chemotherapy could identify patients with estrogen receptor-positive breast cancer tumors who will not respond optimally to preoperative chemotherapy.
|
MRI screening for women considered to be at high or moderate risk for breast cancer is more effective in the detection of the disease in the early stages than either half-yearly digital ultrasound and/or annual mammography, according to a recent prospective study published online Feb. 22 in the Journal of Clinical Oncology.
Microbubbles conjugated to small peptide-targeting ligands can provide ultrasound imaging signals allowing researchers to visualize tumor activity at the molecular level and show its progression, according to research published in the March issue of the Journal of Nuclear Medicine.
The combination of MR imaging and mammography can provide a cost-effective way of improving life expectancy for women who have an increased risk of breast cancer, according to a study published online today in the March issue of Radiology.
Stereotactic- and ultrasonography-guided core-needle biopsy procedures may be considered to be nearly as accurate as open surgical biopsy, with lower complication rates for average-risk women suspected of having breast cancer, according to an article published in the Feb. 16 issue of Annals of Internal Medicine.
An intense three-week course of radiation therapy is just as effective as the standard five-week regimen for women with early-stage breast cancer, according to a study in the Feb. 11 issue of the New England Journal of Medicine.
Hypofractionated radiotherapy regimens for the treatment of breast cancer patients does not result in increased physical side effects in the breast or detriment to body image and is equally as effective at reducing the risk of further cancer in the breast, which can lead to better quality of life for patients, according to the results of the START study published online Feb. 8 in the Lancet Oncology.
The national mammography guidelines for breast cancer screening that were published in a report by the U.S. Preventive Services Task Force (USPSTF) in the Annals of Internal Medicine in November 2009 have come under fire by an article published online in the December 2009 edition of the Journal of Diagnostic Medical Sonography.
First Coast Oncology in Jacksonville, Fla., has added a Naviscan PEM (Positron Emission Mammography) scanner and will use both a PEM scanner and the AccuBoost image guided breast irradiation procedure for breast cancer therapy.
Cognitively impaired elderly women are found to often undergo mammography screening despite the lack of any probable benefit and guidelines should be established against screening this subgroup of women, said a study published in the Jan. 14 online edition of the American Journal of Public Health.
Myriad Genetics has entered into an agreement with Mammography Reporting System (MRS) to help increase the identification of patients at high risk for hereditary breast cancer.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.